University of Minnesota granted Cellectis exclusive, worldwide rights to use inventions related to transcription activator-like effector-mediated DNA recognition and cleavage for all uses in any field

University of Minnesota

U.S. / Academic

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Cellectis S.A.

France / Small-Cap Biopharma (<$1 billion)

$106.4m on 01/21/2011 [market cap]

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced